Cite

HARVARD Citation

    Lee, H. et al. (2020). Anti‐myeloma potential of ruxolitinib in co‐existing JAK2V617F‐positive smouldering myeloma and polycythaemia vera. British journal of haematology. pp. e114-e118. [Online]. 
  
Back to record